CureVac's mRNA vaccine seems to be a failure at sub-50% efficacy.
Novavax just got more incredible data from their UK trials. Matches up pretty close with US trial results.
Quote:
|
Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the publication of results from the final analysis of a pivotal Phase 3 clinical trial of its COVID-19 vaccine candidate conducted in the United Kingdom in the New England Journal of Medicine (NEJM). The final analysis confirmed an overall efficacy of 89.7% with over 60% (half) of the cases caused by the B.1.1.7 (Alpha) variant, and a 96.4% efficacy against non-B.1.1.7 (non-Alpha) variants which represents strains most similar to the original virus.
|
If you are worried about mRNA, this seems like the best option so far. No idea if it can get Emergency Authorization before pfizer gets full though.